Early-demographic dividend vs Turkmenistan: Immunization, Hib3
Immunization, Hib3 over time
- Early-demographic dividend
- Turkmenistan
How they compare
Turkmenistan currently reports 98.0% against 86.1% in Early-demographic dividend, a difference of 11.9%.
That makes Turkmenistan's figure about 1.1 times Early-demographic dividend's.
Across all 15 years both countries report, Turkmenistan has been ahead every year.
Early-demographic dividend ranks 17th and Turkmenistan ranks 20th of 43 groups.
Turkmenistan has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Early-demographic dividend | Turkmenistan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.9% | 91.4% | 29.5% | Turkmenistan |
| 2020s | 84.4% | 98.0% | 13.6% | Turkmenistan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Early-demographic dividend or Turkmenistan?
- Turkmenistan, at 98.0% against 86.1% in Early-demographic dividend as of 2024.
- What is the difference in immunization, hib3 between Early-demographic dividend and Turkmenistan?
- 11.9%, with Turkmenistan ahead.
- How many years of comparable data are there for Early-demographic dividend and Turkmenistan?
- 15 years are reported by both, from 2010 to 2024.
- How do Early-demographic dividend and Turkmenistan rank globally for immunization, hib3?
- Early-demographic dividend ranks 17th and Turkmenistan ranks 20th of 43 groups.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.